Click for best price
Swine Mycoplasma Vaccine Market Size, Share 2024
| Market size in 2023 |
US$ 665.7 million
|
Forecast Market size by 2030 |
US$ 1101.9 million
|
| Growth Rate |
CAGR of 7.5% |
Number of Pages |
72 Pages |
The global Swine Mycoplasma Vaccine market was valued at US$ 665.7 million in 2023 and is projected to reach US$ 1101.9 million by 2030, at a CAGR of 7.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Inactivated Vaccines Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Swine Mycoplasma Vaccine include Zoetis, Boehringer Ingelheim, Jinhe Biotechnology, Merck, HIPRA, Ceva Sant? Animale, Harbin Pharmaceutical Group, Pulike Biotech and Qilu Animal Health Products, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Swine mycoplasma vaccine is a type of vaccine that is designed to prevent mycoplasma infections in pigs. Mycoplasmas are bacteria that can cause a variety of respiratory and reproductive diseases in pigs, such as enzootic pneumonia, arthritis, and urinary tract infections.
This report aims to provide a comprehensive presentation of the global market for Swine Mycoplasma Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Mycoplasma Vaccine. This report contains market size and forecasts of Swine Mycoplasma Vaccine in global, including the following market information:
- Global Swine Mycoplasma Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Swine Mycoplasma Vaccine Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Swine Mycoplasma Vaccine companies in 2023 (%)
We surveyed the Swine Mycoplasma Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Swine Mycoplasma Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Swine Mycoplasma Vaccine Market Segment Percentages, by Type, 2023 (%)
- Inactivated Vaccines
- Live Vaccines
Global Swine Mycoplasma Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Swine Mycoplasma Vaccine Market Segment Percentages, by Application, 2023 (%)
Global Swine Mycoplasma Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Swine Mycoplasma Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Swine Mycoplasma Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Swine Mycoplasma Vaccine revenues share in global market, 2023 (%)
- Key companies Swine Mycoplasma Vaccine sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Swine Mycoplasma Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Zoetis
- Boehringer Ingelheim
- Jinhe Biotechnology
- Merck
- HIPRA
- Ceva Sant? Animale
- Harbin Pharmaceutical Group
- Pulike Biotech
- Qilu Animal Health Products
- Wuhan Keqian Biology
- Guangdong Winsun Bio-Pharmaceutical
- Including or excluding key companies relevant to your analysis.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Swine Mycoplasma Vaccine, market overview.
Chapter 2: Global Swine Mycoplasma Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Swine Mycoplasma Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Mycoplasma Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Swine Mycoplasma Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Swine Mycoplasma Vaccine Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 665.7 million
|
| Forecast Market size by 2030 |
US$ 1101.9 million
|
| Growth Rate |
CAGR of 7.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Swine Mycoplasma Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Swine Mycoplasma Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Swine Mycoplasma Vaccine Overall Market Size
2.1 Global Swine Mycoplasma Vaccine Market Size: 2023 VS 2030
2.2 Global Swine Mycoplasma Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Swine Mycoplasma Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top Swine Mycoplasma Vaccine Players in Global Market
3.2 Top Global Swine Mycoplasma Vaccine Companies Ranked by Revenue
3.3 Global Swine Mycoplasma Vaccine Revenue by Companies
3.4 Global Swine Mycoplasma Vaccine Sales by Companies
3.5 Global Swine Mycoplasma Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Swine Mycoplasma Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Swine Mycoplasma Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Swine Mycoplasma Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Swine Mycoplasma Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Swine Mycoplasma Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Swine Mycoplasma Vaccine Market Size Markets, 2023 & 2030
4.1.2 Inactivated Vaccines
4.1.3 Live Vaccines
4.2 By Type - Global Swine Mycoplasma Vaccine Revenue & Forecasts
4.2.1 By Type - Global Swine Mycoplasma Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Swine Mycoplasma Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global Swine Mycoplasma Vaccine Sales & Forecasts
4.3.1 By Type - Global Swine Mycoplasma Vaccine Sales, 2019-2024
4.3.2 By Type - Global Swine Mycoplasma Vaccine Sales, 2025-2030
4.3.3 By Type - Global Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global Swine Mycoplasma Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Swine Mycoplasma Vaccine Market Size, 2023 & 2030
5.1.2 Piglets
5.1.3 Adult Pigs
5.2 By Application - Global Swine Mycoplasma Vaccine Revenue & Forecasts
5.2.1 By Application - Global Swine Mycoplasma Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Swine Mycoplasma Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global Swine Mycoplasma Vaccine Sales & Forecasts
5.3.1 By Application - Global Swine Mycoplasma Vaccine Sales, 2019-2024
5.3.2 By Application - Global Swine Mycoplasma Vaccine Sales, 2025-2030
5.3.3 By Application - Global Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global Swine Mycoplasma Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Swine Mycoplasma Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Swine Mycoplasma Vaccine Revenue & Forecasts
6.2.1 By Region - Global Swine Mycoplasma Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Swine Mycoplasma Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global Swine Mycoplasma Vaccine Sales & Forecasts
6.3.1 By Region - Global Swine Mycoplasma Vaccine Sales, 2019-2024
6.3.2 By Region - Global Swine Mycoplasma Vaccine Sales, 2025-2030
6.3.3 By Region - Global Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Swine Mycoplasma Vaccine Revenue, 2019-2030
6.4.2 By Country - North America Swine Mycoplasma Vaccine Sales, 2019-2030
6.4.3 US Swine Mycoplasma Vaccine Market Size, 2019-2030
6.4.4 Canada Swine Mycoplasma Vaccine Market Size, 2019-2030
6.4.5 Mexico Swine Mycoplasma Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Swine Mycoplasma Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe Swine Mycoplasma Vaccine Sales, 2019-2030
6.5.3 Germany Swine Mycoplasma Vaccine Market Size, 2019-2030
6.5.4 France Swine Mycoplasma Vaccine Market Size, 2019-2030
6.5.5 U.K. Swine Mycoplasma Vaccine Market Size, 2019-2030
6.5.6 Italy Swine Mycoplasma Vaccine Market Size, 2019-2030
6.5.7 Russia Swine Mycoplasma Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries Swine Mycoplasma Vaccine Market Size, 2019-2030
6.5.9 Benelux Swine Mycoplasma Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Swine Mycoplasma Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia Swine Mycoplasma Vaccine Sales, 2019-2030
6.6.3 China Swine Mycoplasma Vaccine Market Size, 2019-2030
6.6.4 Japan Swine Mycoplasma Vaccine Market Size, 2019-2030
6.6.5 South Korea Swine Mycoplasma Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia Swine Mycoplasma Vaccine Market Size, 2019-2030
6.6.7 India Swine Mycoplasma Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Swine Mycoplasma Vaccine Revenue, 2019-2030
6.7.2 By Country - South America Swine Mycoplasma Vaccine Sales, 2019-2030
6.7.3 Brazil Swine Mycoplasma Vaccine Market Size, 2019-2030
6.7.4 Argentina Swine Mycoplasma Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Swine Mycoplasma Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Swine Mycoplasma Vaccine Sales, 2019-2030
6.8.3 Turkey Swine Mycoplasma Vaccine Market Size, 2019-2030
6.8.4 Israel Swine Mycoplasma Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia Swine Mycoplasma Vaccine Market Size, 2019-2030
6.8.6 UAE Swine Mycoplasma Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Zoetis
7.1.1 Zoetis Company Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Swine Mycoplasma Vaccine Major Product Offerings
7.1.4 Zoetis Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 Zoetis Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Swine Mycoplasma Vaccine Major Product Offerings
7.2.4 Boehringer Ingelheim Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Jinhe Biotechnology
7.3.1 Jinhe Biotechnology Company Summary
7.3.2 Jinhe Biotechnology Business Overview
7.3.3 Jinhe Biotechnology Swine Mycoplasma Vaccine Major Product Offerings
7.3.4 Jinhe Biotechnology Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 Jinhe Biotechnology Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Swine Mycoplasma Vaccine Major Product Offerings
7.4.4 Merck Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 HIPRA
7.5.1 HIPRA Company Summary
7.5.2 HIPRA Business Overview
7.5.3 HIPRA Swine Mycoplasma Vaccine Major Product Offerings
7.5.4 HIPRA Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 HIPRA Key News & Latest Developments
7.6 Ceva Sant? Animale
7.6.1 Ceva Sant? Animale Company Summary
7.6.2 Ceva Sant? Animale Business Overview
7.6.3 Ceva Sant? Animale Swine Mycoplasma Vaccine Major Product Offerings
7.6.4 Ceva Sant? Animale Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Ceva Sant? Animale Key News & Latest Developments
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Company Summary
7.7.2 Harbin Pharmaceutical Group Business Overview
7.7.3 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Major Product Offerings
7.7.4 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.8 Pulike Biotech
7.8.1 Pulike Biotech Company Summary
7.8.2 Pulike Biotech Business Overview
7.8.3 Pulike Biotech Swine Mycoplasma Vaccine Major Product Offerings
7.8.4 Pulike Biotech Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.8.5 Pulike Biotech Key News & Latest Developments
7.9 Qilu Animal Health Products
7.9.1 Qilu Animal Health Products Company Summary
7.9.2 Qilu Animal Health Products Business Overview
7.9.3 Qilu Animal Health Products Swine Mycoplasma Vaccine Major Product Offerings
7.9.4 Qilu Animal Health Products Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.9.5 Qilu Animal Health Products Key News & Latest Developments
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Company Summary
7.10.2 Wuhan Keqian Biology Business Overview
7.10.3 Wuhan Keqian Biology Swine Mycoplasma Vaccine Major Product Offerings
7.10.4 Wuhan Keqian Biology Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.10.5 Wuhan Keqian Biology Key News & Latest Developments
7.11 Guangdong Winsun Bio-Pharmaceutical
7.11.1 Guangdong Winsun Bio-Pharmaceutical Company Summary
7.11.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Business Overview
7.11.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Major Product Offerings
7.11.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Sales and Revenue in Global (2019-2024)
7.11.5 Guangdong Winsun Bio-Pharmaceutical Key News & Latest Developments
8 Global Swine Mycoplasma Vaccine Production Capacity, Analysis
8.1 Global Swine Mycoplasma Vaccine Production Capacity, 2019-2030
8.2 Swine Mycoplasma Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Swine Mycoplasma Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Swine Mycoplasma Vaccine Supply Chain Analysis
10.1 Swine Mycoplasma Vaccine Industry Value Chain
10.2 Swine Mycoplasma Vaccine Upstream Market
10.3 Swine Mycoplasma Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Swine Mycoplasma Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Swine Mycoplasma Vaccine in Global Market
Table 2. Top Swine Mycoplasma Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Swine Mycoplasma Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Swine Mycoplasma Vaccine Revenue Share by Companies, 2019-2024
Table 5. Global Swine Mycoplasma Vaccine Sales by Companies, (K Units), 2019-2024
Table 6. Global Swine Mycoplasma Vaccine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Swine Mycoplasma Vaccine Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Swine Mycoplasma Vaccine Product Type
Table 9. List of Global Tier 1 Swine Mycoplasma Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Swine Mycoplasma Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Swine Mycoplasma Vaccine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Swine Mycoplasma Vaccine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Swine Mycoplasma Vaccine Sales (K Units), 2019-2024
Table 15. By Type - Global Swine Mycoplasma Vaccine Sales (K Units), 2025-2030
Table 16. By Application ? Global Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Swine Mycoplasma Vaccine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Swine Mycoplasma Vaccine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Swine Mycoplasma Vaccine Sales (K Units), 2019-2024
Table 20. By Application - Global Swine Mycoplasma Vaccine Sales (K Units), 2025-2030
Table 21. By Region ? Global Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Swine Mycoplasma Vaccine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Swine Mycoplasma Vaccine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Swine Mycoplasma Vaccine Sales (K Units), 2019-2024
Table 25. By Region - Global Swine Mycoplasma Vaccine Sales (K Units), 2025-2030
Table 26. By Country - North America Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Swine Mycoplasma Vaccine Sales, (K Units), 2019-2024
Table 29. By Country - North America Swine Mycoplasma Vaccine Sales, (K Units), 2025-2030
Table 30. By Country - Europe Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Swine Mycoplasma Vaccine Sales, (K Units), 2019-2024
Table 33. By Country - Europe Swine Mycoplasma Vaccine Sales, (K Units), 2025-2030
Table 34. By Region - Asia Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Swine Mycoplasma Vaccine Sales, (K Units), 2019-2024
Table 37. By Region - Asia Swine Mycoplasma Vaccine Sales, (K Units), 2025-2030
Table 38. By Country - South America Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Swine Mycoplasma Vaccine Sales, (K Units), 2019-2024
Table 41. By Country - South America Swine Mycoplasma Vaccine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Swine Mycoplasma Vaccine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Swine Mycoplasma Vaccine Sales, (K Units), 2025-2030
Table 46. Zoetis Company Summary
Table 47. Zoetis Swine Mycoplasma Vaccine Product Offerings
Table 48. Zoetis Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Zoetis Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Swine Mycoplasma Vaccine Product Offerings
Table 52. Boehringer Ingelheim Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Jinhe Biotechnology Company Summary
Table 55. Jinhe Biotechnology Swine Mycoplasma Vaccine Product Offerings
Table 56. Jinhe Biotechnology Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Jinhe Biotechnology Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Swine Mycoplasma Vaccine Product Offerings
Table 60. Merck Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. HIPRA Company Summary
Table 63. HIPRA Swine Mycoplasma Vaccine Product Offerings
Table 64. HIPRA Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. HIPRA Key News & Latest Developments
Table 66. Ceva Sant? Animale Company Summary
Table 67. Ceva Sant? Animale Swine Mycoplasma Vaccine Product Offerings
Table 68. Ceva Sant? Animale Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Ceva Sant? Animale Key News & Latest Developments
Table 70. Harbin Pharmaceutical Group Company Summary
Table 71. Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Product Offerings
Table 72. Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Harbin Pharmaceutical Group Key News & Latest Developments
Table 74. Pulike Biotech Company Summary
Table 75. Pulike Biotech Swine Mycoplasma Vaccine Product Offerings
Table 76. Pulike Biotech Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Pulike Biotech Key News & Latest Developments
Table 78. Qilu Animal Health Products Company Summary
Table 79. Qilu Animal Health Products Swine Mycoplasma Vaccine Product Offerings
Table 80. Qilu Animal Health Products Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Qilu Animal Health Products Key News & Latest Developments
Table 82. Wuhan Keqian Biology Company Summary
Table 83. Wuhan Keqian Biology Swine Mycoplasma Vaccine Product Offerings
Table 84. Wuhan Keqian Biology Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Wuhan Keqian Biology Key News & Latest Developments
Table 86. Guangdong Winsun Bio-Pharmaceutical Company Summary
Table 87. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Product Offerings
Table 88. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Guangdong Winsun Bio-Pharmaceutical Key News & Latest Developments
Table 90. Swine Mycoplasma Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 91. Global Swine Mycoplasma Vaccine Capacity Market Share of Key Manufacturers, 2022-2024
Table 92. Global Swine Mycoplasma Vaccine Production by Region, 2019-2024 (K Units)
Table 93. Global Swine Mycoplasma Vaccine Production by Region, 2025-2030 (K Units)
Table 94. Swine Mycoplasma Vaccine Market Opportunities & Trends in Global Market
Table 95. Swine Mycoplasma Vaccine Market Drivers in Global Market
Table 96. Swine Mycoplasma Vaccine Market Restraints in Global Market
Table 97. Swine Mycoplasma Vaccine Raw Materials
Table 98. Swine Mycoplasma Vaccine Raw Materials Suppliers in Global Market
Table 99. Typical Swine Mycoplasma Vaccine Downstream
Table 100. Swine Mycoplasma Vaccine Downstream Clients in Global Market
Table 101. Swine Mycoplasma Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Swine Mycoplasma Vaccine Segment by Type in 2023
Figure 2. Swine Mycoplasma Vaccine Segment by Application in 2023
Figure 3. Global Swine Mycoplasma Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Swine Mycoplasma Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Swine Mycoplasma Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. Swine Mycoplasma Vaccine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Swine Mycoplasma Vaccine Revenue in 2023
Figure 9. By Type - Global Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 12. By Type - Global Swine Mycoplasma Vaccine Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 16. By Application - Global Swine Mycoplasma Vaccine Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Swine Mycoplasma Vaccine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 21. By Country - North America Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 23. US Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 28. Germany Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. France Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 37. China Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. India Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 44. Brazil Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Swine Mycoplasma Vaccine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Swine Mycoplasma Vaccine Sales Market Share, 2019-2030
Figure 48. Turkey Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Swine Mycoplasma Vaccine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Swine Mycoplasma Vaccine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Swine Mycoplasma Vaccine by Region, 2023 VS 2030
Figure 54. Swine Mycoplasma Vaccine Industry Value Chain
Figure 55. Marketing Channels
